Search results
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 7 days agoAlnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat...
Gear Up for Alnylam (ALNY) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks· 2 days agoFree Report) will announce quarterly loss of $0.75 per share in its forthcoming report, representing an increase of 46.4% year over year. Over the past 30 days, the consensus EPS estimate for ...
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in...
WFRV 5 Green Bay· 2 days ago(Nasdaq: ALNY), the leading RNAi therapeutics company, announced today a further expansion of their existing partnership in Central & Eastern Europe and Israel, to also include...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 21 hours agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Annexon (ANNX) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 19 hours agoAnnexon (ANNX) is expected to provide updates from the phase III study evaluating its lead...
What's in the Cards for Amgen (AMGN) This Earnings Season?
Zacks via Yahoo Finance· 3 days agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is...
Potential Effects of the Inflation Reduction Act on Orphan Drug Development | JD Supra
JD Supra· 1 day agoPresident Biden signed the Inflation Reduction Act (IRA) into law on Aug. 16, 2022, with the goal of reducing health care costs for the government and participants in Medicare and Medicaid programs ...
State’s highest paid CEO reports major drop in compensation - Boston Business Journal
The Business Journals· 6 days agoThe highest-paid chief executive in Massachusetts last year will likely drop completely off the...